Announcements Trials
Browse Landscape

Phase

Phase 1/2 4Phase 2 3Phase 1 1

Status

Terminated 4Completed 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Prostatic Neoplasms 1Mesothelioma, Malignant 1Melanoma 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

pembrolizumab 73Carboplatin 60Cyclophosphamide 59Nivolumab 52Paclitaxel 47Gemcitabine 44Cisplatin 43Dexamethasone 41Radiotherapy 36Rituximab 32Capecitabine 32Bevacizumab 29Docetaxel 28fludarabine 27atezolizumab 26Cytarabine 26avelumab 24venetoclax 23Trastuzumab 23Oxaliplatin 23Lenalidomide 23Cetuximab 23Azacitidine 23Ipilimumab 22Fluorouracil 22Temozolomide 21130-nm albumin-bound paclitaxel 21fludarabine phosphate 20Filgrastim 20Bortezomib 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Terminated × vatalanib × Clear all
NCT00615160 2021-10-06

PTK/ZK in Disseminated Malignant Melanoma

University Hospital Schleswig-Holstein

Phase 1/2 Terminated
9 enrolled
Dermatologic

Melanoma

NCT00216047 2015-12-09

PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer

Hoosier Cancer Research Network

Phase 1/2 Terminated
7 enrolled
Breast

Breast Neoplasms

NCT00293371 2012-10-11

Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer

University of California, San Francisco

Phase 1/2 Terminated
6 enrolled
Genitourinary

Prostatic Neoplasms

NCT00281125 2012-03-19

Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer

Nevada Cancer Institute

Phase 1/2 Terminated
20 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡